Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Date

28 February 2022

AMR.Solutions: Fireside Chat about AMR Benchmark Report

The Access to Medicine Foundation's Fatema Rafiqi joined AMR expert John Rex for a 'fireside chat', exploring both the findings of the 2021 Antimicrobial Resistance Benchmark and Fatema's personal journey and career thus far.

John Rex's newsletter, AMR.Solutions, is highly regarded within the AMR world – sharing all the most important news on developments in the R&D pipeline, stewardship, events and more. 

In a video interview featured in the latest edition of the newsletter, John spoke with Fatema Rafiqi about the Access to Medicine Foundation's work on antimicrobial resistance (AMR). During the in-depth interview, Fatema shared insights into the results of the Benchmark, which saw signs of progress in some areas – but also identified many opportunities for pharmaceutical companies to step up in the fight against AMR. 

The findings of the 2021 AMR Benchmark had already been featured in the AMR.Solutions newsletter shortly after publication in November 2021; however, this 'Fireside Chat' interview was a chance to follow up on the data and conclusions in more detail.

Watch the video on YouTube.

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved